BRPI0515983A - antagonistas não peptìdicos da bradicinina, composições farmacêuticas compreendendo os mesmos e uso - Google Patents
antagonistas não peptìdicos da bradicinina, composições farmacêuticas compreendendo os mesmos e usoInfo
- Publication number
- BRPI0515983A BRPI0515983A BRPI0515983-0A BRPI0515983A BRPI0515983A BR PI0515983 A BRPI0515983 A BR PI0515983A BR PI0515983 A BRPI0515983 A BR PI0515983A BR PI0515983 A BRPI0515983 A BR PI0515983A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- peptide
- bradykinin antagonists
- peptide bradykinin
- compounds
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 239000003152 bradykinin antagonist Substances 0.000 title 1
- 101800004538 Bradykinin Proteins 0.000 abstract 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 abstract 2
- 102100035792 Kininogen-1 Human genes 0.000 abstract 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000001370 alpha-amino acid derivatives Chemical group 0.000 abstract 1
- 235000008206 alpha-amino acids Nutrition 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"ANTAGONISTA NãO PEPTìCOS DA BRADICININA, COMPOSIçõES FARMACêUTICAS COMPREENDEDO OS MESMOS E USO".A presente invenção refere-se a compostos não-peptícos tendo atividades como antagonistas seletivos do receptor da bradicinina (BK) B2. Os compostos são quimicamente caracterizados pela presença de um aminoácido alfa substituido por um grupo cíclico e por um grupo de tetraalquilamónio.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001963A ITMI20041963A1 (it) | 2004-10-15 | 2004-10-15 | "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche" |
| PCT/EP2005/010412 WO2006040004A1 (en) | 2004-10-15 | 2005-09-27 | Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0515983A true BRPI0515983A (pt) | 2008-08-12 |
Family
ID=35810869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0515983-0A BRPI0515983A (pt) | 2004-10-15 | 2005-09-27 | antagonistas não peptìdicos da bradicinina, composições farmacêuticas compreendendo os mesmos e uso |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7645759B2 (pt) |
| EP (1) | EP1799214B8 (pt) |
| JP (1) | JP4980917B2 (pt) |
| CN (1) | CN101039671B (pt) |
| AR (1) | AR051392A1 (pt) |
| AT (1) | ATE381931T1 (pt) |
| AU (1) | AU2005293881B2 (pt) |
| BR (1) | BRPI0515983A (pt) |
| CA (1) | CA2583920C (pt) |
| CY (1) | CY1107254T1 (pt) |
| DE (1) | DE602005004039T2 (pt) |
| DK (1) | DK1799214T3 (pt) |
| EA (1) | EA010913B1 (pt) |
| ES (1) | ES2299090T3 (pt) |
| GE (1) | GEP20115322B (pt) |
| HR (1) | HRP20080107T3 (pt) |
| IL (1) | IL182494A (pt) |
| IT (1) | ITMI20041963A1 (pt) |
| MA (1) | MA29007B1 (pt) |
| MX (1) | MX2007004297A (pt) |
| NO (1) | NO339805B1 (pt) |
| NZ (1) | NZ554469A (pt) |
| PL (1) | PL1799214T3 (pt) |
| PT (1) | PT1799214E (pt) |
| RS (1) | RS50563B (pt) |
| SI (1) | SI1799214T1 (pt) |
| UA (1) | UA86091C2 (pt) |
| WO (1) | WO2006040004A1 (pt) |
| ZA (1) | ZA200703009B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20041963A1 (it) * | 2004-10-15 | 2005-01-15 | Luso Farmaco Inst | "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche" |
| EP2086935A1 (de) | 2006-10-16 | 2009-08-12 | Grünenthal GmbH | Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| ITMI20072225A1 (it) * | 2007-11-23 | 2009-05-24 | Luso Farmaco Inst | "composizioni farmaceutiche a base di antagonisti della bradichinina ed acido ialuronico e loro uso" |
| IT1391236B1 (it) * | 2008-07-11 | 2011-12-01 | St Luso Farm D'italia Spa | Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso |
| WO2015155323A1 (en) * | 2014-04-10 | 2015-10-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Br2 antagonist for use in the prevention of the hypotensive effect of patient treated with angiotensin-converting enzyme inhibitors (acei) |
| CA3037157A1 (en) * | 2016-09-16 | 2018-03-22 | Dyax Corp. | Metabolite biomarkers for diseases associated with the contact activation system |
| IL274883B2 (en) | 2017-11-24 | 2023-11-01 | Pharvaris Netherlands B V | BRADYKININ B2 receptor antagonists |
| AR118982A1 (es) * | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| UY38707A (es) * | 2019-05-23 | 2020-12-31 | Pharvaris Gmbh | Nuevos antagonistas cíclicos del receptor b2 de bradiquinina |
| EP4499100A1 (en) | 2022-03-25 | 2025-02-05 | Pharvaris GmbH | Therapeutic uses of bradykinin b2-receptor antagonists |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
| HRP20260166T1 (hr) | 2022-03-25 | 2026-03-27 | Pharvaris Gmbh | Čvrsti sastav koji sadrži solubilizirane antagoniste bradikinin b2 receptora |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20021247A1 (it) * | 2002-06-07 | 2003-12-09 | Menarini Ricerche Spa | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche |
| ITMI20041963A1 (it) * | 2004-10-15 | 2005-01-15 | Luso Farmaco Inst | "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche" |
| EP1741444A1 (en) * | 2005-07-05 | 2007-01-10 | Jerini AG | Kinin antagonists for treating bladder dysfunction |
-
2004
- 2004-10-15 IT IT001963A patent/ITMI20041963A1/it unknown
-
2005
- 2005-09-27 ES ES05789989T patent/ES2299090T3/es active Active
- 2005-09-27 PL PL05789989T patent/PL1799214T3/pl unknown
- 2005-09-27 GE GEAP20059985A patent/GEP20115322B/en unknown
- 2005-09-27 MX MX2007004297A patent/MX2007004297A/es active IP Right Grant
- 2005-09-27 SI SI200530175T patent/SI1799214T1/sl unknown
- 2005-09-27 DE DE602005004039T patent/DE602005004039T2/de active Active
- 2005-09-27 PT PT05789989T patent/PT1799214E/pt unknown
- 2005-09-27 RS RSP-2008/0110A patent/RS50563B/sr unknown
- 2005-09-27 WO PCT/EP2005/010412 patent/WO2006040004A1/en not_active Ceased
- 2005-09-27 DK DK05789989T patent/DK1799214T3/da active
- 2005-09-27 CN CN2005800348339A patent/CN101039671B/zh not_active Expired - Fee Related
- 2005-09-27 UA UAA200702710A patent/UA86091C2/ru unknown
- 2005-09-27 EA EA200700584A patent/EA010913B1/ru not_active IP Right Cessation
- 2005-09-27 HR HR20080107T patent/HRP20080107T3/xx unknown
- 2005-09-27 JP JP2007536029A patent/JP4980917B2/ja not_active Expired - Fee Related
- 2005-09-27 EP EP05789989A patent/EP1799214B8/en not_active Expired - Lifetime
- 2005-09-27 NZ NZ554469A patent/NZ554469A/en not_active IP Right Cessation
- 2005-09-27 ZA ZA200703009A patent/ZA200703009B/xx unknown
- 2005-09-27 BR BRPI0515983-0A patent/BRPI0515983A/pt not_active Application Discontinuation
- 2005-09-27 AU AU2005293881A patent/AU2005293881B2/en not_active Ceased
- 2005-09-27 CA CA2583920A patent/CA2583920C/en not_active Expired - Fee Related
- 2005-09-27 AT AT05789989T patent/ATE381931T1/de active
- 2005-10-14 AR ARP050104324A patent/AR051392A1/es not_active Application Discontinuation
-
2007
- 2007-04-10 US US11/786,041 patent/US7645759B2/en not_active Expired - Fee Related
- 2007-04-11 NO NO20071840A patent/NO339805B1/no not_active IP Right Cessation
- 2007-04-12 IL IL182494A patent/IL182494A/en not_active IP Right Cessation
- 2007-05-04 MA MA29870A patent/MA29007B1/fr unknown
-
2008
- 2008-03-20 CY CY20081100314T patent/CY1107254T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071840L (no) | Ikke-peptid bradykininantagonister og farmasoytiske sammensetninger derav. | |
| BRPI0605921B8 (pt) | compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas | |
| DE60222396D1 (de) | N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste | |
| BR9911621A (pt) | Bifenil sulfonamidas como antagonista duplos de receptor de angiotensina endotelina | |
| BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
| ECSP13012771A (es) | Compuestos heterocíclicos nitrogenados sustituidos fusionados en posición 6,6 y usos de los mismos | |
| GB0130347D0 (en) | Compounds | |
| BRPI0407827A (pt) | compostos de aminoeteroarila como inibidores de proteìna cinase | |
| GT200900187A (es) | Derivados de oxindol sustituido, medicamentos que los comprenden y uso los mismos | |
| DE602005014382D1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb-kinaseinhibitoren | |
| BRPI0414593A (pt) | derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1 | |
| PH12020550683A1 (en) | Novel bradykinin b2 receptor antagonists | |
| DK1755634T3 (da) | Oligopeptider til formindskelse af forhöjet blodurinstofkoncentration | |
| BR0311825A (pt) | Antagonistas de bradicinina de não-peptìdeo básicos e composições farmacêuticas dos mesmos | |
| BRPI0506858A (pt) | composto, métodos de preparação de monoidrato de gaboxadol cristalino e de anidrato de gaboxadol cristalino, composição farmacêutica, e, uso de um composto | |
| EA201201662A1 (ru) | Дизамещенные тетрагидрофуранильные соединения в качестве антагонистов брадикининового рецептора в1 | |
| ATE284398T1 (de) | N-imidazolyl-alkyl substituierte cyklische amine als histamin-h3 agonisten oder antagonisten | |
| TR201907381T4 (tr) | Beta-laktamil fenilalanin, sistein ve serin vazopressin antagonisti. | |
| ATE519498T1 (de) | Kombination aus somatostatin-analoga unterschiedlicher selektivität für humane somatostatin-rezeptor-subtypen | |
| BRPI0406704A (pt) | Antagonistas de 5ht~7~ e agonistas inversos | |
| BRPI0511999A (pt) | compostos como antagonistas de ccr5 | |
| BR112018071548A2 (pt) | compostos heterocíclicos bicíclicos substituídos | |
| TR200909785A1 (tr) | Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar. | |
| WO2010118286A3 (en) | Benzimidazole modulators of h1 receptor and/or ns4b protein activity | |
| BR0317363A (pt) | Antagonista de npy-5 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |